4295 articles
With iconic London landmarks as its campaign backdrop, William Morris unveiled its fall winter collection for brands Black Label and London. Uniquely angular Black Label model Luna is a featured frame, bursting with design details. Available in blue, green and red, its translucent acetate colourways
Senior lecturer Dr Phil Turnbull at the School of Optometry and Vision Science (SOVS), University of Auckland, has received the Butland Award for his work developing a virtual patient for optometry students.
Gene therapy has partly restored the function of the retina’s cone receptors in two children who were born completely colourblind, reported University College London (UCL) researchers.
A UK clinical trial found subthreshold micropulse laser therapy for diabetic macular oedema (DMO) offers comparable results to standard-threshold laser and costs less than one-tenth of anti-VEGF injections.
Boosting its dry eye family of products, Medix21 has introduced Rayner’s Aeon pre- and post-surgery eye drops to help manage patients’ dry eye and improve visual outcomes.
A new gene therapy targeting malfunctioning mitochondria has shown “robust benefit” in disease models as the first potential treatment for dry age-related macular degeneration (AMD).
Re:Vision is a finalist in three categories of this year’s Westpac Awards: best emerging business, excellence in customer service delivery, and excellence in community contribution.
Sharing the spotlight with its dry eye diagnostics, Ophthalmic Instrument Company (OIC) introduced Avizor’s Ever Clean Plus lens care system to New Zealand’s ophthalmic community at this year’s CCLS conference.
Micro-invasive glaucoma surgery pioneer Glaukos announced its iStent family of technologies have now been implanted in more than one million procedures worldwide.
The Wellington Eye Centre has become the first laser clinic in New Zealand to take delivery of the VISUMAX 800 femtosecond laser made by Carl Zeiss Meditec.
A Spanish study of patients with age-related macular degeneration (AMD) found the rate of visual decline increased significantly and irreversibly during the Covid-19 lockdown. Analysing the effects
A US study demonstrated elevated flavoprotein fluorescence (FPF) in optic nerve mitochondria can indicate early glaucoma, with researchers saying their method could be a more accurate diagnostic tool